批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
>>>原始批准或临时批准<<<
| 审批日期 | 提交号 | 审批结论 | 提交分类 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2009/10/08 |
ORIG-1(原始申请) |
Approval |
|
|
|
|
>>>补充申请<<<
| 审批日期 | 提交号 | 审批结论 | 补充类别或审批类型 | 审评优先级;罕用药状态 | 通知信、审评文件、说明书、包装标签 | 备注 |
| 2025/02/21 |
SUPPL-36(补充) |
Approval |
REMS - MODIFIED - D-N-A |
|
|
|
| 2024/03/20 |
SUPPL-30(补充) |
Approval |
REMS - MODIFIED - D-N-A |
|
|
|
| 2023/12/15 |
SUPPL-33(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2023/10/18 |
SUPPL-31(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/12/16 |
SUPPL-29(补充) |
Approval |
REMS - MODIFIED - D-N-A |
|
|
|
| 2022/06/17 |
SUPPL-28(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/06/17 |
SUPPL-26(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2022/05/03 |
SUPPL-27(补充) |
Approval |
REMS - MODIFIED - D-N-A |
|
|
|
| 2021/11/24 |
SUPPL-24(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2021/03/04 |
SUPPL-21(补充) |
Approval |
Labeling-Medication Guide,Labeling-Package Insert |
STANDARD
|
|
|
| 2021/02/08 |
SUPPL-20(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2019/10/07 |
SUPPL-18(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2018/10/31 |
SUPPL-16(补充) |
Approval |
REMS - MODIFIED - D-N-A |
|
|
|
| 2018/02/01 |
SUPPL-15(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2017/05/23 |
SUPPL-13(补充) |
Approval |
REMS-Modified |
|
|
|
| 2016/12/16 |
SUPPL-12(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/12/16 |
SUPPL-11(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2016/07/07 |
SUPPL-10(补充) |
Approval |
REMS-Modified |
|
|
|
| 2015/02/12 |
SUPPL-6(补充) |
Approval |
REMS-Modified |
|
|
|
| 2015/02/04 |
SUPPL-7(补充) |
Approval |
Labeling-Package Insert |
STANDARD
|
|
|
| 2013/09/04 |
SUPPL-5(补充) |
Approval |
REMS-Modified |
|
|
|
| 2013/02/22 |
SUPPL-4(补充) |
Approval |
Labeling-Medication Guide,REMS-Proposal |
STANDARD
|
|
|
| 2013/02/21 |
SUPPL-3(补充) |
Approval |
Labeling-Medication Guide,Labeling-Container/Carton Labels,Labeling-Package Insert |
STANDARD
|
|
|
与本品相关的专利信息(来自FDA橙皮书Orange Book)
| 关联产品号 | 专利号 | 专利过期日 | 是否物质专利 | 是否产品专利 | 专利用途代码 | 撤销请求 | 提交日期 | 专利下载 | 备注 |
| 无 |
与本品治疗等效的药品
>>>活性成分:BUPRENORPHINE HYDROCHLORIDE; 剂型/给药途径:TABLET;SUBLINGUAL; 规格:EQ 2MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 078633 |
001 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2009/10/08
|
HIKMA |
| 090622 |
001 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2010/09/24
|
ETHYPHARM |
| 090819 |
001 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2015/02/19
|
ACTAVIS ELIZABETH |
| 090279 |
001 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2015/06/10
|
RUBICON RESEARCH |
| 201760 |
001 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2016/01/29
|
SUN PHARM |
| 207276 |
001 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 2MG BASE |
Prescription |
No |
No |
AB |
2017/03/27
|
RHODES PHARMS |
>>>活性成分:BUPRENORPHINE HYDROCHLORIDE; 剂型/给药途径:TABLET;SUBLINGUAL; 规格:EQ 8MG BASE; 治疗等效代码:AB<<<
| 申请号 | 产品号 | 申请类型 | 商品名 | 活性成分 | 剂型/给药途径 | 规格 | 市场状态 | RLD | RS | TE Code | 产品号批准日期 | 申请人 |
| 078633 |
002 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 8MG BASE |
Prescription |
No |
Yes |
AB |
2009/10/08
|
HIKMA |
| 090622 |
002 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 8MG BASE |
Prescription |
No |
No |
AB |
2010/09/24
|
ETHYPHARM |
| 090819 |
002 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 8MG BASE |
Prescription |
No |
No |
AB |
2015/02/19
|
ACTAVIS ELIZABETH |
| 090279 |
002 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 8MG BASE |
Prescription |
No |
No |
AB |
2015/06/10
|
RUBICON RESEARCH |
| 201760 |
002 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 8MG BASE |
Prescription |
No |
No |
AB |
2016/01/29
|
SUN PHARM |
| 207276 |
002 |
ANDA |
BUPRENORPHINE HYDROCHLORIDE |
BUPRENORPHINE HYDROCHLORIDE |
TABLET;SUBLINGUAL |
EQ 8MG BASE |
Prescription |
No |
No |
AB |
2017/03/27
|
RHODES PHARMS |